ArticleCell reports. Medicine2025
Frontoparietal network mediates the antidepressant effects of accelerated iTBS and cTBS: TMS-EEG study.
Article in Cell reports. Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Neurophysiological signatures of Stanford Neuromodulation Therapy in treatment resistant depression.Molecular psychiatry · 2026Article
- Intermittent Theta-Burst Stimulation (iTBS) Improves Motor Coordination and Modulates Neuroinflammation and Autophagy in SCA3/MJD Mice.Cerebellum (London, England) · 2026Article
- Motor Cortex rTMS Alleviates Pain and Comorbid Depression After Spinal Cord Injury with a Correlate in M1 Intracortical Inhibition.Journal of pain research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accelerated intermittent and continuous theta burst stimulation (a-iTBS and a-cTBS) show strong efficacy for treatment-resistant depression (TRD), yet their neural mechanisms remain unclear. This study uses concurrent transcranial magnetic stimulation (TMS) and electroencephalography (TMS-EEG) to examine these mechanisms in 40 TRD patients and 40 healthy controls (HCs). TRD individuals demonstrate abnormal local cortical excitability at baseline, characterized by left hypoactivity and right disinhibition. A-iTBS increases left excitability, and a-cTBS increases right inhibition, and both normalize it to the level of HCs. Network analyses reveal that a-iTBS improves current propagation to the left inferior parietal lobule (IPL), correlating with a better antidepressant effect. Contrastingly, a-cTBS induces a widespread inhibition as indicated by current propagation over parietal cortices, with the left IPL being most prominent, and this also correlates with a better antidepressant effect. These findings outline the frontoparietal circuitry in TMS antidepressant effects and provide insights for optimizing treatment efficacy. This study was registered at the Chinese Clinical Trial Registry (ChiCTR2200055320).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.